What have antidepressants done to Gen Z’s relationships?
The New York Times Magazine published an article last week about the lesser-discussed ways selective serotonin reuptake inhibitors, such as…
Guwahati’s pill-picking habit deepens as self-medication becomes norm
Guwahati, Nov 17: For Surangana Goswami, reaching for a pill has slowly become second nature. What started as…
Evenity not advised for patients with a high heart attack risk
Dear Dr. Roach: My primary care doctor has prescribed the medication Evenity for my osteoporosis. I have been…
Tirzepatide may only temporarily suppress brain activity involved in “food noise”
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on…
Young People Are Tripping on Benadryl—and It’s Always a Bad Time
There’s a figure who may greet you during an intense Benadryl trip. Faceless, shrouded in black with red…
FDA Unveils New Path for Approving Drugs for Just One Patient
US regulators laid out new guidelines for approving custom-made treatments for individual patients, a move that could bring…
Off-label GLP-1 use highlights the cultural pressures driving body anxieties
A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as…
Woman says winning £127,000 was ‘worst day of my life’
Lisa Walker said her life spiralled out of control Kate Lally SEO writer and Neil Shaw 10:48, 13…
Innovative research reveals FGD3 as a key player in breast cancer cell death
A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the…
Breakthroughs in theranostic nanomaterials for traumatic brain injury management
Traumatic brain injury (TBI) remains one of the most pressing public health challenges, leaving millions with lasting disabilities…
GLP-1 drugs linked to improved survival in colon cancer patients
A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists –…
FDA Chaos Threatens US Biomedical Innovation and Patients Health
The US Food and Drug Administration under a second Trump administration is mired in discord, acrimony and chaos…